A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 775
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : EC
Long Form : esophageal cancer
No. Year Title Co-occurring Abbreviation
1982 Diet and vitamin nutrition of the high esophageal cancer risk population in Linxian, China. ---
1986 Malignant transformation of human fetal lung fibroblasts induced by nitrosamine compounds in vitro. MAMBNA, NDEA
1988 A prospective study of esophageal cytological atypia in Linxian county. LX
1988 Comparison of chromosomal aberrations in epithelium adjacent to esophageal cancer (EC) and in esophageal cancer cell line EC8501. ---
1988 G-banded chromosome analyses of mucosal epithelium adjacent to esophageal cancer (EC)--some consistent chromosomal changes. ---
1988 Selenium and other mineral elements in populations at risk for esophageal cancer. Se
1989 Radiotherapy alone and chemoradiation for nonmetastatic esophageal carcinoma. A critical review of chemoradiation. CR, RT, RT-CT
1990 [Genetic epidemiology of esophageal cancer: 10-year follow-up of 622 positive families in Yangcheng County]. ---
1992 Esophageal cancer in Shanxi Province, People's Republic of China: a case-control study in high and moderate risk areas. ---
10  1992 Infectious agents in the etiology of esophageal cancer. ---
11  1992 Modelling the relative risk of esophageal cancer in a case-control study. ---
12  1992 [Overexpression of p53 protein in human spontaneous esophageal carcinoma and fetal esophageal carcinoma induced by N-methyl-N-benzylnitrosamine (NMBzA)]. NMBzA
13  1993 [Mutation and expression of Rb gene in human esophageal cancer]. ---
14  1994 [Alterations of oncogenes in human fetal esophageal epithelium induced by N-methylbenzylnitrosamine (NMBzA)]. HFE, NMBzA
15  1994 [Mutation of p53 gene in human cancers of the esophagus and gastric cardia]. ---
16  1995 [Correlation studies on the alterations of multiple tumor suppressor genes in human esophageal cancer and in human and monkey esophageal epithelial cells treated with N-methyl-N-benzyl nitrosamine]. NMBzA
17  1995 [Detection of serum isoferritin level in 195 patients with cancer]. LC, NPC, SIF
18  1995 [Preliminary study on relationship between syndrome differentiation of esophageal cancer and changes of exfoliated cells of tongue coating]. ---
19  1996 Genetic alterations on chromosomes 3 and 9 of esophageal cancer tissues from China. LOH, MIN
20  1996 Procedures of simultaneous radical resection indicated for primary synchronous esophageal and liver cancers--from the personal experience of three cases. CCC, EN, HCC
21  1996 Relationship of esophageal dysplasia to associated head and neck cancer in patients with esophageal carcinoma. CIS, HNC, MID, MOD, SD
22  1996 [Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xian]. ---
23  1997 Mutations of O6-methylguanine-DNA methyltransferase gene in esophageal cancer tissues from Northern China. MGMT
24  1997 [Isolation and identification of DNA fragments frequently deleted from tumor cell lines of human esophageal cancer]. ---
25  1997 [Possible significance of novel DNA fragments frequently deleted from tumor cell lines of human esophageal cancer]. ---
26  1998 Distinct regions of frequent loss of heterozygosity of chromosome 5p and 5q in human esophageal cancer. ADC, LOH, PCR, SCC
27  1998 Overexpression of P53 and its risk factors in esophageal cancer in urban areas of Xi'an. ---
28  1998 [Association of fragile histidine triad gene (FHIT) with susceptibility to esophageal cancer. A preliminary study]. FHIT, LOH
29  1998 [Cloning and identification of cDNA fragments related to human esophageal cancer]. ECRG
30  1998 [Establishment of two human esophageal carcinoma cell lines and their cytogenetic analysis]. CGH, FISH
31  1998 [Molecular cytogenetic study on four human esophageal cancer cell lines]. CGH, FISH
32  1998 [Study on the status of methylation of Rb gene promoter in human esophageal cancer and effect of NMBzA on Rb gene promoter in monkey esophageal epithelium]. ---
33  1999 Mapping of novel regions of DNA gain and loss by comparative genomic hybridization in esophageal carcinoma in the Black and Colored populations of South Africa. ---
34  1999 Nested case-control study of esophageal cancer in relation to occupational exposure to silica and other dusts. SPMR
35  2000 Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India. ESCCs, p53-Abs
36  2000 Nutrient intake and esophageal cancer in the Caspian littoral of Iran: a case-control study. ---
37  2000 Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. CRT, CS, KPS, RR, RT
38  2000 Thoracoscopic and laparoscopic staging for esophageal cancer. ---
39  2000 Use of minimally invasive surgery in staging esophageal cancer. ---
40  2000 Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. CT, EUS, FDG, LN, PET
41  2000 [Study on family aggregation of esophageal cancer in Linzhou city]. RR
42  2001 Computed tomographic staging of esophageal cancer and prognosis. CT
43  2001 Discovery and occurrence of the fumonisins: a historical perspective. ELEM, PPE
44  2001 Outcomes of radiotherapy for inoperable locally advanced (T4) esophageal cancer-retrospective analysis-. CR, FU, MST
45  2001 Pretreatment surgical lymph node staging predicts results of trimodality therapy in esophageal cancer. ---
46  2001 [30-year experiences on early detection and treatment of esophageal cancer in high risk areas]. ---
47  2001 [Detection of HPV in human esophageal cancer in high-incidence area and its correlation with p53 expression]. IS-PCR, ISH
48  2002 Cytotoxicity of fumonisin B1, diethylnitrosamine, and catechol on the SNO esophageal cancer cell line. CAT, DEN, FB1
49  2002 Endoscopic screening and determination of p53 and proliferating cell nuclear antigen in esophageal multistage carcinogenesis: a comparative study between high- and low-risk populations in Henan, northern China. BCH, DYS, HIA, LIA, PCNA, SCC
50  2002 Field population-based blocking treatment of esophageal epithelia dysplasia. EBC, MEED, SEED I, SEED II, ZSP
51  2002 Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. DGT
52  2002 Relationship of tobacco smoking CYP1A1 GSTM1 gene polymorphism and esophageal cancer in Xi'an. ---
53  2002 Trimodality treatment versus surgery alone for esophageal cancer. A stratified analysis with minimally invasive pretreatment staging. ---
54  2003 An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. ---
55  2003 On the nature of genetic changes required for the development of esophageal cancer. ---
56  2003 Periodic pharyngolaryngoscopy detects early head and neck cancer and improves survival in esophageal cancer. SCCs
57  2003 Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. PDT
58  2003 Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa. ESCC
59  2003 Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. EGJ, GCA, IM, SCC
60  2004 Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. GC, ICP-DRC-MS
61  2004 Effects of neoadjuvant radio-chemotherapy on 18F-FDG-PET in esophageal carcinoma. PET, pre, SUV
62  2004 Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. ---
63  2004 Genetic susceptibility and environmental factors of esophageal cancer in Xi'an. ---
64  2004 Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1. EC9706, FLNA, GST
65  2004 Mycoflora of Iranian maize harvested in the main production areas in 2000. ---
66  2004 p53 polymorphism in human papillomavirus-associated Kazakh's esophageal cancer in Xinjiang, China. HPV, PCR, PCR-RFLP, SCC
67  2004 [A case-control study on the polymorphisms of methylenetetrahydrofolate reductase 1298A-->C and susceptibility of esophageal cancer]. ---
68  2004 [Preoperative chemoradiation in esophageal cancer: experience of a single center in 102 patients]. ---
69  2005 Age scope of high-risk population for esophageal cancer in Ci county. SEED II, SEEDI
70  2005 Association of functional polymorphisms of SLC11A1 with risk of esophageal cancer in the South African Colored population. SCC
71  2005 Decrease in the esophageal cancer incidence rate in mountainous but not level parts of Cixian County, China, over 29 years. ASR
72  2005 Novel targeted therapies in the treatment of gastric and esophageal cancer. GC
73  2005 Predictors of esophageal cancer risk: assessment of susceptibility to DNA damage using comet assay. BPDE, CI, OR
74  2005 Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. GERD, LC, qPCR
75  2005 Relationship between genetic polymorphisms of metabolizing enzymes CYP2E1, GSTM1 and Kazakh's esophageal squamous cell cancer in Xinjiang, China. GST, PCR, RFLP
76  2005 Riboflavin deficiency and esophageal cancer: a case control-household study in the Caspian Littoral of Iran. CIs, EGRAC, ORs
77  2005 [Molecular genetics on fumonisin-producing strains of Fusarium verticillioides]. PKS, PPE
78  2006 Association of smoking, alcohol drinking and dietary factors with esophageal cancer in high- and low-risk areas of Jiangsu Province, China. OR
79  2006 Comparative genomic hybridization: comparison between esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-incidence area for both cancers in Henan, northern China. CGH, GCA, SCC
80  2006 Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance. ASR, DCO
81  2006 Genomic instability in precancerous lesions before inactivation of tumor suppressors p53 and APC in patients. APC, BE, FISH, GIN, HGD, ME
82  2006 Management of locoregional stage esophageal cancer: a single center experience. ---
83  2006 Novel targets in gastric and esophageal cancer. GC
84  2006 Polo-like kinase and survivin are esophageal tumor-specific promoters. ---
85  2006 Positron emission tomography in the staging of esophageal cancer. CT, EUS, EUS-FNA
86  2006 Preoperative staging of esophageal carcinoma with multidetector CT and virtual endoscopy. MDCT, VE
87  2006 Reconstruction of upper digestive tract: reducing morbidity by laparoscopic pull-up. LGPU
88  2006 Successful outcome after combined chemotherapeutic and surgical management in a case of esophageal cancer with breast and brain relapse. ---
89  2006 [Relationship between smoking and risk of esophageal cancer in 103 areas in China: a large-scale case-control study incorporated into a nationwide survey of mortality]. ---
90  2006 [Study of gastric function after esophagectomy and cardiectomy with vagus nerve preserved and reconstruction of gastric funds in patients with esophageal and cardiac cancer]. CC, VPRG, VSNG
91  2007 Anatomical subsite discrepancy in relation to the impact of the consumption of alcohol, tobacco and betel quid on esophageal cancer. AOR, SCC
92  2007 Association between esophageal cancer and drought in China by using Geographic Information System. GIS
93  2007 Clinical impact of lymphadenectomy extent in resectable esophageal cancer. eLND, LNs, OS
94  2007 Esophageal cancer: biology, natural history, staging and therapeutic options. EUS
95  2007 Expression and roles of keratinocyte growth factor and its receptor in esophageal cancer cells. KGF, KGFR
96  2007 Head and neck cancer associated with esophageal cancer. SCCHN, SCCs
97  2007 mtDNA evidence: genetic background associated with related populations at high risk for esophageal cancer between Chaoshan and Taihang Mountain areas in China. mtDNA
98  2007 Pretreatment gene expression profiles can be used to predict response to neoadjuvant chemoradiotherapy in esophageal cancer. AC, CRT, SCC
99  2007 Soil and vegetation characteristics of high- and low-risk areas of esophageal cancer in China. SOCD
100  2007 Targeted agents and esophageal cancer--the next step? ---
101  2007 Temporal trends of esophageal cancer during 1995-2004 in Nanao Island, an extremely high-risk area in China. ASR, CC
102  2007 The Association of Beta-catenin Gene Mutations and Human Papillomavirus in Carcinoma of Esophagus in a High-Risk Population of India. ESCC, HPV
103  2007 Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. mRNA, MV, RT-PCR
104  2007 Using NHANES oral health examination protocols as part of an esophageal cancer screening study conducted in a high-risk region of China. DMFT, MGI, NHANES
105  2008 A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. AC, SCC
106  2008 Antiproliferation and apoptosis induction of paeonol in human esophageal cancer cell lines. Pae
107  2008 Association of interleukin-6 (-174G>C) promoter polymorphism with risk of squamous cell esophageal cancer and tumor location: an exploratory study. IL-6, SCC
108  2008 Cost-effectiveness of palliation of unresectable esophageal cancer. CE, ICER, NHB, SES, WTP
109  2008 DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese. SNP
110  2008 ECRG1, a novel esophageal gene, cloned and identified from human esophagus and its inhibition effect on tumors. ECRG-1, GFP
111  2008 Effect of local therapy for the treatment of superficial esophageal cancer in non-operative candidates. ---
112  2008 Esophageal and gastric cardia cancers on 4238 Chinese patients residing in municipal and rural regions: a histopathological comparison during 24-year period. EAC, ESCC, GCA
113  2008 Esophageal cancer risk by type of alcohol drinking and smoking: a case-control study in Spain. CI
114  2008 Expression of matrix metalloproteinase-9 in the neoplastic and interstitial inflammatory infiltrate cells in the different histopathological types of esophageal cancer. ---
115  2008 High incidence of non-upper aerodigestive primary tumors in patients with esophageal cancer. CRC, OPTs, SIR, SIR
116  2008 Interaction of EGFR 497Arg>Lys with EGF +61A>G polymorphism: modulation of risk in esophageal cancer. SCC
117  2008 Interaction of methylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. CYP4502E1, MTHER, RFLP
118  2008 Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest. GSK-3beta, RT-PCR
119  2008 Microsatellite alterations in phenotypically normal esophageal squamous epithelium and metaplasia-dysplasia-adenocarcinoma sequence. ADC, LOH, MSI, PCR, SCC
120  2008 Multipoint quantification of multimarker genes in peripheral blood and micrometastasis characteristic in peri-operative esophageal cancer patients. PB
121  2008 Potential influence of interleukin-1 haplotype IL-1 beta-511*T-IL-1RN*1 in conferring low risk to middle third location of esophageal cancer: a case-control study. CI, IL, OR
122  2008 Proteomic identification of malignant transformation-related proteins in esophageal squamous cell carcinoma. CypA, FTCD, hnRNP L, Prx1
123  2008 Relationships between esophageal cancer and spatial environment factors by using Geographic Information System. DI, NDVI, PCA, WHI
124  2008 Role of silis in esophageal cancer. ---
125  2008 The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients. CEA, MMP-9, MMPs, SCC
126  2008 The value of narrow band imaging endoscope for early head and neck cancers. NBI, SCCHN
127  2008 [Comparative study on soil and vegetation characteristics from high- and low risk areas of esophageal cancer in China]. SOCD
128  2008 [Study on the ingestion of folate and polymorphism of MTHFR C677T with esophageal cancer in Xinjiang Kazakh]. MTHFR, PCR-RFLP
129  2008 [Study on the relationship between polymorphisms of XPA gene and susceptibility of esophageal cancer]. PCR-RFLP, XPA
130  2009 Association of human leukocyte antigen and esophageal cancer in North of Iran. SCC
131  2009 Constitutive short telomere length of chromosome 17p and 12q but not 11q and 2p is associated with an increased risk for esophageal cancer. ---
132  2009 Esophagectomy for T1 esophageal cancer: outcomes in 100 patients and implications for endoscopic therapy. DFS, OS, T1a
133  2009 Expression profiles of early esophageal squamous cell carcinoma by cDNA microarray. ESCC
134  2009 Genetic variants of the XRCC1 gene and susceptibility to esophageal cancer: a meta-analysis. XRCC1
135  2009 High-temperature beverages and foods and esophageal cancer risk--a systematic review. ---
136  2009 Interaction of total N-nitroso compounds in environment and in vivo on risk of esophageal cancer in the coastal area, China. NAAs, TEA, TNOCs
137  2009 Patterns of food and nutrient consumption in northern Iran, a high-risk area for esophageal cancer. LTIs, RDAs
138  2009 The influence of deprivation and ethnicity on the incidence of esophageal cancer in England. EAC, ESCC
139  2009 [A 1:2 matched case-control study on the interaction of HPV16E6 and HLA-DR9 allele to esophageal cancer in Kazakh ethnicity, Xinjiang]. ---
140  2009 [Characterization of the changes in comparative genomic hybridization in esophageal cancer patients with family history]. CGH
141  2009 [Clinicopathological characteristics and survival outcome of esophageal cancer. Results from a series of 200 patients]. EUS, IC
142  2009 [DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: a meta-analysis]. EAC, ESCC
143  2009 [Metabonomic variation of esophageal cancer within different ethnic groups in Xinjiang, China]. OPLS-DA
144  2009 [Population-based case-control family study on risk factors of esophageal cancer in high incidence area]. ---
145  2009 [Study on the association of cytochrome P450 polymorphisms and the risk of esophageal cancer: a meta-analysis]. EAC, ESCC
146  2010 Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. CI, EADC, ESCC, GST, OR
147  2010 Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers. CEA, HGFs, M-CSF, ROC, SCC-Ag
148  2010 Controllable metastasis: the trap for the esophageal cancer cells? ---
149  2010 Esophageal cancer in young people: a case series of 109 cases and review of the literature. ESCC
150  2010 Estrogen analogues: promising target for prevention and treatment of esophageal squamous cell carcinoma in high risk areas. ER, ESCC, HIA, LIA
151  2010 Genetic diagnosis of patients with esophageal cancer using FISH. FISH
152  2010 Heredity, diet and lifestyle as determining risk factors for the esophageal cancer on Nanao Island in Southern China. SIR
153  2010 Molecular cytogenetic characterization of esophageal cancer detected by comparative genomic hybridization. CGH
154  2010 p21 Waf1/Cip1 polymorphisms and risk of esophageal cancer. CI, OR, PCR, SNP
155  2010 Predictors of cervical and recurrent laryngeal lymph node metastases from esophageal cancer. CRL
156  2010 Soils selenium level and esophageal cancer: an ecological study in a high risk area for esophageal cancer. Se
157  2010 The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. BMI, DFS, EAC, HR, OS, PVD
158  2010 The low expression of CD80 correlated with the vascular endothelial growth factor in esophageal cancer tissue. RT-PCR, VEGF
159  2010 TP53 mutation profile of esophageal squamous cell carcinomas of patients from Southeastern Brazil. ESCC
160  2010 Y-chromosome evidence for common ancestry of three Chinese populations with a high risk of esophageal cancer. CSP, FJP, HTMP, Y-STR
161  2010 [Analysis of the esophageal cancer mortality in 2004 - 2005 and its trends during last 30 years in China]. CASR, WASR
162  2011 A Poisson regression approach for modelling spatial autocorrelation between geographically referenced observations. AIC, BIC, SIRs
163  2011 A rare case of esophageal cancer (T2N0) with a solitary cerebellar metastasis. ---
164  2011 An expert opinion on esophageal cancer therapy. CMT
165  2011 Angiogenesis-related molecular targets in esophageal cancer. ---
166  2011 Association between alcohol consumption and cancers in the Chinese population--a systematic review and meta-analysis. OR, RR
167  2011 Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley. CI, MMP-7, MMPs, PCR-RFLP
168  2011 Association of mitochondrial haplogroup D and risk of esophageal cancer in Taihang Mountain and Chaoshan areas in China. mtDNA
169  2011 Association of TP53 intron 3, 16 bp duplication polymorphism with esophageal and gastric cancer susceptibility in Kashmir Valley. bp, GC
170  2011 Barrett's esophagus: treatment or observation of a major precursor factor of esophageal cancer? BE
171  2011 Clinical results of definitive chemoradiotherapy for patients with synchronous head and neck squamous cell carcinoma and esophageal cancer. HNSCC
172  2011 Cyclooxygenase-2 polymorphisms and susceptibility to esophageal cancer: a meta-analysis. COX-2, ESCC
173  2011 Does the association of 18F-FDG uptake intensity and lesion topography reveal histological phenotype and tumor differentiation in esophageal cancer? ESCC, PD, WD
174  2011 Epidemiologic risk factors for esophageal cancer development. ---
175  2011 Esophageal cancer in northwestern Iran. ---
176  2011 Esophageal cancer mortality trends during the last 30 years in high risk areas in China: comparison of results from national death surveys conducted in the 1970's, 1990's and 2004-2005. ASMRc, ASMRw, CMR, PMR
177  2011 Estimating the costs of esophageal cancer screening, early diagnosis and treatment in three high risk areas in China. ---
178  2011 Glasgow Prognostic Score is a predictor of perioperative and long-term outcome in patients with only surgically treated esophageal cancer. CRP, GPS, SI
179  2011 Healthcare utilization in patients with esophageal cancer in a high risk area in northeast of Iran. DUI, TUI
180  2011 p53 codon 72 polymorphism and the risk of esophageal cancer: a Korean case-control study. ---
181  2011 Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer. miRNA, Plk1
182  2011 Primary lung cancer surgery after curative chemoradiotherapy for esophageal cancer patients. CRT
183  2011 Primary placement technique of jejunostomy using the entristar™ skin-level gastrostomy tube in patients with esophageal cancer. G-tube, QOL, SLJT
184  2011 Quality of life in patients with esophageal stenting for the palliation of malignant dysphagia. HRQoL, SEMS
185  2011 Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. CI, OR, PCR, RFLP, SCC
186  2011 The expression of CXCR4 and its relationship with matrix metalloproteinase-9/vascular endothelial growth factor in esophageal squamous cell cancer. CXCR4, ESCC, MMP-9, TNM, VEGF
187  2011 The GNAS1 T393C single nucleotide polymorphism predicts the natural postoperative course of complete resected esophageal cancer. SNP
188  2011 The spatial distribution of esophageal and gastric cancer in Caspian region of Iran: an ecological analysis of diet and socio-economic influences. GC, SIRs
189  2011 TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis. CIs, ORs
190  2012 A 10-year study of esophageal cancer in Guilan province, Iran: the Guilan Cancer Registry Study (GCRS). ADC, ASR, GCRS, SCC
191  2012 ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients. CK, DTC, HR, OS, s-ALCAM
192  2012 Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: a meta-analysis. CIs, ORs, XPD
193  2012 Barrett's esophagus and esophageal cancer: an overview. AC, BE
194  2012 Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008. ASR, GPCR, IARC
195  2012 Chemo/tomotherapy stereotactic body radiation therapy (chemo/SBRT) for the salvage treatment of esophageal carcinoma following trimodality therapy: a case report. ---
196  2012 Cholecystectomy and the risk of esophageal and gastric cancer. CIs, EAC, GC, SRRs
197  2012 Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. CI, OS, pathCR, PET
198  2012 Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus). AUC, CEA, CRP, SCC-Ag
199  2012 Comparisons of curative and side effects of chemoradiotherapy among Xinjiang Han, Uigur and Kazakh esophageal carcinoma patients. ---
200  2012 Cost-benefit analysis of esophageal cancer endoscopic screening in high-risk areas of China. BCRs, NPVs
201  2012 Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: A meta-analysis of 17 case-control studies. CIs, CYP2E1, ORs
202  2012 Diagnostic accuracy of EUS in differentiating mucosal versus submucosal invasion of superficial esophageal cancers: a systematic review and meta-analysis. SEC, SROC
203  2012 Disseminated tumor cells in bone marrow and the natural course of resected esophageal cancer. CI, DTC, HR
204  2012 Drug resistance-related microRNAs in esophageal cancer. miRNAs
205  2012 Effect of altered WIG-1 expression on DDP sensitivity in a DDP-resistant esophageal squamous cancer cell line. GFP, WIG-1
206  2012 EPHX1 polymorphisms do not modify esophageal carcinoma susceptibility in Dutch Caucasians. EAC, mEH
207  2012 Esophageal cancer mortality during 2004-2009 in Yanting County, China. APC
208  2012 Esophageal cancer risk is associated with polymorphisms of DNA repair genes MSH2 and WRN in Chinese population. OR
209  2012 Esophageal cancer tumorspheres involve cancer stem-like populations with elevated aldehyde dehydrogenase enzymatic activity. ALDH, CSCs
210  2012 Extensive mediastinal lymphadenectomy during minimally invasive esophagectomy: optimal results from a single center. MIE, RLN
211  2012 Fumonisin B1 contamination of cereals and risk of esophageal cancer in a high risk area in northeastern Iran. FB1
212  2012 High enzyme activity UGT1A1 or low activity UGT1A8 and UGT2B4 genotypes increase esophageal cancer risk. EAC, ESCC
213  2012 Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients. AD, CEA, IL-6, SCC-Ag
214  2012 Human leukocyte antigen class I on peripheral blood mononuclear cells as a non-invasive biomarker for esophageal cancer. HLA-I, PBMCs
215  2012 Identification of estrogen responsive genes using esophageal squamous cell carcinoma (ESCC) as a model. cTFBSs, EREs, ESCC, TFBSs
216  2012 Interleukin 6 and C-reactive protein in esophageal cancer. CRP, IL-6
217  2012 Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C>T polymorphism with esophageal cancer risk. CI, NQO1, OR
218  2012 MicroRNAs in esophageal cancer (review). miRNAs
219  2012 New Tween-80 microbiological assay of serum folate levels in humans and animals. Tween-80 MBA
220  2012 None-endoscopic Screening for Esophageal Squamous Cell Carcinoma- A Review. ESCC, ESD
221  2012 Null association of NQO1 609C>T and NQO2 -3423G>A polymorphisms with susceptibility and prognosis of Esophageal cancer in north Indian population and meta-analysis. NQO1, NQO2
222  2012 Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation. PET
223  2012 Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. H-BMI
224  2012 Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer. AC, CAIX, DFS, pSTAT3, STAT3
225  2012 Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. ESCC, PAHs
226  2012 Quality of drinking water and high incidence rate of esophageal cancer in Golestan province of Iran: a probable link. MCL
227  2012 Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. CIs, DM, SRRs
228  2012 Role of NQO1 609C>T and NQO2 -3423G>A gene polymorphisms in esophageal cancer risk in Kashmir valley and meta analysis. NQO1, NQO2
229  2012 Role of p53 and p73 genes polymorphisms in susceptibility to esophageal cancer: a case control study in a northern Indian population. ---
230  2012 Saliva supernatant miR-21: a novel potential biomarker for esophageal cancer detection. ---
231  2012 Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients. CEA, SCC
232  2012 The clinical application of 4D 18F-FDG PET/CT on gross tumor volume delineation for radiotherapy planning in esophageal squamous cell cancer. CI, GTV, SUV, VR
233  2012 The effect of socioeconomic status on staging and treatment decisions in esophageal cancer. CI, SES
234  2012 The levels of zinc and molybdenum in hair and food grain in areas of high and low incidence of esophageal cancer: a comparative study. ---
235  2012 The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer. MMPs
236  2012 The role of selenium and selected trace elements in the etiology of esophageal cancer in high risk Golestan province of Iran. Se, Sr, Zn
237  2012 Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison. c-IMRT, CI, MU, NTCP, OAR, PTV, VMAT
238  2012 XPD Lys751Gln polymorphism and esophageal cancer susceptibility: a meta-analysis of case-control studies. EADC, ESCC, OR, XPD
239  2012 [Genetic polymorphisms of ADH1B and ALDH-2 associated with risk of esophageal cancer: a meta-analysis]. ADH1B, ALDH2, OR
240  2012 [Preliminary experience of clinical applications of the 7th UICC-AJCC TNM staging system of esophageal carcinoma]. OS
241  2012 [Research progress of prognostic protein biomarkers associated with esophagus squamous cell carcinoma]. ESCC
242  2013 A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer. CI, IC, OS, pathCR
243  2013 Aflatoxin contamination of wheat flour and the risk of esophageal cancer in a high risk area in Iran. AF
244  2013 Analysis of risk factors associated with precancerous lesion of gastric cancer in patients from eastern China: a comparative study. CAG, GC, GERD, GP, GU, HP, PLGC
245  2013 Association between CYP1A1 polymorphisms and esophageal cancer: a meta-analysis. CYP1A1
246  2013 Association between the c.910A>G genetic variant of the XRCC1 gene and susceptibility to esophageal cancer in the Chinese Han population. CI, OR, XRCC1
247  2013 Component analysis of esophageal cancer incidence in Kazakhstan. ---
248  2013 Differential expression of miRNAs in esophageal cancer tissue. miRNAs
249  2013 Effects of green tea, black tea, and coffee consumption on the risk of esophageal cancer: a systematic review and meta-analysis of observational studies. CNKI, OR
250  2013 Endoluminal high-dose-rate brachytherapy for early stage and recurrent esophageal cancer in medically inoperable patients. CI, HDR, OFFF, OS
251  2013 Endoscopic screening for esophageal squamous cell carcinoma. ESCC, NBI
252  2013 Epidemiology of esophageal cancer in Yanting - regional report of a national screening programme in China. CIS, HH, IC, INC, LH, MH
253  2013 Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992-2005. AC, ASR, CIs, NHB, NHW, PRs, RR, SCC, SRR, US
254  2013 Expression of KIAA0101 protein is associated with poor survival of esophageal cancer patients and resistance to cisplatin treatment in vitro. aCGH
255  2013 Fish consumption and risk of esophageal cancer and its subtypes: a systematic review and meta-analysis of observational studies. CIs, EAC, ESCC, SRRs
256  2013 Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance. TMT
257  2013 Is there a role for surgery for patients with a complete clinical response after chemoradiation for esophageal cancer? An intention-to-treat case-control study. cCR, CI, CRT
258  2013 Lymph node dissection for esophageal cancer. LN
259  2013 Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer. ESCC
260  2013 Meta-analysis demonstrates association of XRCC1 genetic polymorphism Arg399Gln with esophageal cancer risk in the Chinese population. OR, XRCC1
261  2013 Metabolic signatures of esophageal cancer: NMR-based metabolomics and UHPLC-based focused metabolomics of blood serum. OPLS-DA, TCA, UHPLC
262  2013 MicroRNA in the pathogenesis and prognosis of esophageal cancer. BE, EAC
263  2013 Modification of risk, but not survival of esophageal cancer patients by esophageal cancer-related gene 1 Arg290Gln polymorphism: a case-control study and meta-analysis. ECRG1, ESCC
264  2013 Mortality trends of gastrointestinal cancers in Iranian population. CRC, GC, GI, HCC, PC
265  2013 Multimodal treatment strategy for clinical T3 thoracic esophageal cancer. NACRT
266  2013 No role for glutathione S-transferase genotypes in Caucasian esophageal squamous cell or adenocarcinoma etiology: an European case-control study. CI, GSTs, OR
267  2013 Patrilineal background of esophageal cancer and gastric cardia cancer patients in a Chaoshan high-risk area in China. GCC, Y-STR
268  2013 Percutaneous radiological gastrostomy in esophageal cancer patients: a feasible and safe access for nutritional support during multimodal therapy. PRG, PRG
269  2013 Polymorphisms in alcohol-metabolizing enzymes and esophageal carcinoma susceptibility: a Dutch Caucasian case-control study. EAC
270  2013 Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers. ---
271  2013 Preoperative treatment of locally advanced esophageal carcinoma (Review). ---
272  2013 Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes. AJCC, ESCC
273  2013 Prognostic significance of preoperative CA72-4 in patients with esophageal squamous cell carcinoma. CA72-4, CI, ESCC, HR, ROC
274  2013 Prognostic value of preoperative serum CA 242 in Esophageal squamous cell carcinoma cases. CA, ESCC, ROC
275  2013 Prognostic value of subcarinal lymph node metastasis in patients with esophageal squamous cell carcinoma. ESCC, LNs
276  2013 Robot-assisted transhiatal esophagectomy: a 3-year single-center experience. RE
277  2013 Role of cancer-related inflammation in esophageal cancer. CRI
278  2013 Role of human papillomaviruses in esophageal squamous cell carcinoma. ESCC, HPV
279  2013 Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. miRNAs, TNM
280  2013 Serum tissue inhibitor of metalloproteinase 1 (TIMP-1) and vascular endothelial growth factor A (VEGF-A) are associated with prognosis in esophageal cancer patients. ELISA, TIMP-1, VEGF-A
281  2013 Short- and long-term survival of esophageal cancer patients treated at the Cancer Institute of Iran. HR
282  2013 Single nucleotide polymorphisms of ADH1B, ADH1C and ALDH2 genes and esophageal cancer: a population-based case-control study in China. ADHs, ALDHs, CI, GWAS, ORs, SNPs
283  2013 Systematic review and meta-analysis of tumor biomarkers in predicting prognosis in esophageal cancer. HRs
284  2013 The methylenetetrahydrofolate reductase C677T polymorphism influences risk of esophageal cancer in Chinese. MTHFR
285  2013 The overexpression of VEGF in esophageal cancer is associated with a more advanced TMN stage: a meta-analysis. OR, OS
286  2013 TP53 gene deletion in esophageal cancer tissues of patients and its clinical significance. FISH
287  2013 Tumor length in elderly patients with esophageal squamous cell carcinoma: is it a prognostic factor? ESCC, ROC
288  2013 Use of the metastatic lymph node ratio to evaluate the prognosis of esophageal cancer patients with node metastasis following radical esophagectomy. AUC, MLR, OS, ROC
289  2013 Utility of serum peptidome patterns of esophageal squamous cell carcinoma patients for comprehensive treatment. ESCC, SVM, WCX-MB
290  2013 [Association research between polymorphism of IFN-gamma and IL-10, environmental risk factors, and susceptibility to esophageal cancer]. IFN-gamma, IL-10
291  2013 [Multiple primary cancers of the esophagus and hepatocellular carcinoma-a report of 4 cases]. HCC, MPC
292  2013 [The study of esophageal cancer risk associated with polymorphisms of DNA damage repair genes XRCC4 and RAD51]. OR
293  2014 18F-fluorodeoxyglucose PET/computed tomography and risk stratification after neoadjuvant treatment in esophageal cancer patients. CT, NAT
294  2014 A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients. 5-FU, CI, dCRT, DFS, HR, OS
295  2014 Abnormal MGMT promoter methylation may contribute to the risk of esophageal cancer: a meta-analysis of cohort studies. CBM, MGMT, OR
296  2014 Adaptation of a quality of life questionnaire for Iranian patients with esophageal cancer. ---
297  2014 An A/C germline single-nucleotide polymorphism in the TNFAIP3 gene is associated with advanced disease stage and survival in only surgically treated esophageal cancer. SNP, TNFAIP3
298  2014 Analysis of TP53 polymorphisms in North Indian sporadic esophageal cancer patients. ---
299  2014 Association between esophageal cancer risk and EPHX1 polymorphisms: a meta-analysis. ---
300  2014 Association of GSTP1 Ile105Val polymorphism with risk of esophageal cancer: a meta-analysis of 21 case-control studies. CIs, EAC, ESCC, GSTP1, ORs
301  2014 Clinical analysis of esophageal cancer patients with a history of metachronous primary cancer. HMPC
302  2014 Clinical application and prognostic assessment of serum Tumor Associated Material (TAM) from esophageal cancer patients. TAM
303  2014 Clinical features of patients with esophageal and second primary cancers. SPC
304  2014 Clinical trial of thalidomide combined with radiotherapy in patients with esophageal cancer. VEGF
305  2014 Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. EET
306  2014 Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma. CRT
307  2014 Comparison of two preoperative inspiratory muscle training programs to prevent pulmonary complications in patients undergoing esophagectomy: a randomized controlled pilot study. IMT-E, IMT-HI, LOS, PPCs
308  2014 Cultivation of circulating tumor cells in esophageal cancer. adenoCA, CTCs, SCC
309  2014 CYP1A1 genetic polymorphisms and risk for esophageal cancer: a case-control study in central China. OR, OR, PCR-RFLP
310  2014 Decoy receptor 3 polymorphisms are not associated with the risk of esophageal cancer in a Chinese population. DcR3, ESCC
311  2014 Dental prophylaxis decreases the risk of esophageal cancer in males; a nationwide population-based study in Taiwan. CI, HR, NHIRD, PD
312  2014 Diet and esophageal cancer risk in the Eastern Cape Province of South Africa. CI, OR
313  2014 Dietary intake of acrylamide and esophageal cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort. EAC, EPIC, ESCC
314  2014 Does timing of surgical procedure after neoadjuvant chemoradiation affect outcomes in esophageal cancer? nCRT
315  2014 Down-regulation of miR-140 induces EMT and promotes invasion by targeting Slug in esophageal cancer. miRNAs
316  2014 EGFR intron-1 CA repeat polymorphism is a predictor of relapse and survival in complete resected only surgically treated esophageal cancer. CA-SSR-1, OS
317  2014 Epidemiological studies of esophageal cancer in the era of genome-wide association studies. EAC, ESCC, GWAS
318  2014 Esophageal Adenocarcinoma and Its Rare Association with Barrett's Esophagus in Henan, China. BE, EAC, ESCC
319  2014 Esophageal cancer in Iran; a population-based study regarding adequacy of cancer surgery and overall survival. ACS
320  2014 Esophageal Cancer in Kazakhstan: Multi-omic Research Challenges. ---
321  2014 Esophageal cancer in Yemen. ADC, SCC
322  2014 Esophageal Cancer: Current Options for Therapeutic Management. ---
323  2014 Evaluation of progression prior to surgery after neoadjuvant chemoradiotherapy with computed tomography in esophageal cancer patients. CRT, CT
324  2014 Extent of lymph node dissection: common hepatic artery lymph node dissection can be omitted for esophageal squamous cell carcinoma. LN
325  2014 Factors relating to quality of life after esophagectomy for cancer patients in Taiwan. EORTC, QOL
326  2014 Functional expression of TLR9 in esophageal cancer. COX-2, CpG ODN, CQ, MMP, TLR9
327  2014 Gender and social disparities in esophagus cancer incidence in Iran, 2003-2009: a time trend province-level study. APC, HDI, SR
328  2014 Gene-environment interactions on the risk of esophageal cancer among Asian populations with the G48A polymorphism in the alcohol dehydrogenase-2 gene: a meta-analysis. ADH2
329  2014 Genetic epidemiological analysis of esophageal cancer in high-incidence areas of China. ---
330  2014 Genetic susceptibility to esophageal cancer due to CYP1A1 gene variant rs4646903 in tobacco addicted patients of Pashtun ethnicity: a case control study in Khyber Pakhtunkhwa province of Pakistan. RT-PCR
331  2014 HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis. ADC, BE, HER2, SCC
332  2014 Human papillomavirus promotes esophageal squamous cell carcinoma by regulating DNA methylation and expression of HLA-DQB1. ESC, ESCC, HPV
333  2014 Identity-by-descent approaches identify regions of importance for genetic susceptibility to hereditary esophageal squamous cell carcinoma. ESCC, IBD
334  2014 Impact of neoadjuvant chemoradiotherapy on postoperative outcomes after esophageal cancer resection: results of a European multicenter study. AL, nCRT
335  2014 Impact of tumor length on survival for patients with resected esophageal cancer. OS
336  2014 Implications of microRNA-197 downregulated expression in esophageal cancer with poor prognosis. TNM
337  2014 Increased risk of thromboembolism in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. CRT, TEEs
338  2014 Is there an association between ABO blood group and overall survival in patients with esophageal squamous cell carcinoma? ESCC
339  2014 Meta-analysis of association studies of CYP1A1 genetic polymorphisms with digestive tract cancer susceptibility in Chinese. CC, CYP1A1, GC, HC
340  2014 Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer. ---
341  2014 MicroRNA-21 promotes cell growth and migration by targeting programmed cell death 4 gene in Kazakh's esophageal squamous cell carcinoma. ESCC, ISH, PDCD4
342  2014 MicroRNAs related polymorphisms and genetic susceptibility to esophageal squamous cell carcinoma. ESCC, SNPs
343  2014 miR-625 down-regulation promotes proliferation and invasion in esophageal cancer by targeting Sox2. ---
344  2014 MiR-96 promotes proliferation and chemo- or radioresistance by down-regulating RECK in esophageal cancer. ---
345  2014 Neoadjuvant chemoradiotherapy for resectable esophageal cancer: an in-depth study of randomized controlled trials and literature review. AC, FU, nCRT, RCTs, SCC
346  2014 NQO1 C609T polymorphism is associated with esophageal cancer risk among Chinese: a meta-analysis. CIs, ORs
347  2014 Perioperative changes in peripheral regulatory B cells of patients with esophageal cancer. CD, FoxP3, IL
348  2014 Phospholipase C epsilon 1 (PLCE1 rs2274223A>G, rs3765524C>T and rs7922612C>T) polymorphisms and esophageal cancer risk in the Kashmir Valley. GWAS, PLCE1
349  2014 PLCE1 rs2274223 polymorphism contributes to risk of esophageal cancer: evidence based on a meta-analysis. CIs, ESCC
350  2014 Polymorphisms in the insulin-like growth factor axis are associated with gastrointestinal cancer. CRC, EAC, ESCC, GHR, GI, HNC, IGF, IGF-I, IGFBPs, ORs, SNPs
351  2014 Prognosis-related microRNAs in esophageal cancer. miRNAs
352  2014 Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands. ---
353  2014 Prognostic impact of clinicopathological features and expression of biomarkers related to (18)F-FDG uptake in esophageal cancer. DFS, FDG, GLUT-I, HIF-Ialpha, HKII, VEGF-C
354  2014 Prognostic significance of Glasgow prognostic score in patients undergoing esophagectomy for esophageal squamous cell carcinoma. CI, CRP, CSS, ESCC, GPS, HR
355  2014 Public health impacts of foodborne mycotoxins. DON, NTDs, OTA
356  2014 Recent advances in oesophageal diseases. ASIR, BE, GERD
357  2014 Selenium levels in rice samples from high and low risk areas for esophageal cancer. Se
358  2014 Simultaneous modulated accelerated radiation therapy for esophageal cancer: a feasibility study. CT, CTV, GTV, LN, PTVs, SMART
359  2014 Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. HR, nCRT
360  2014 Systematic review of zinc biomarkers and esophageal cancer risk. ---
361  2014 Tea and coffee consumption and risk of esophageal cancer: the European prospective investigation into cancer and nutrition study. EAC, ESCC
362  2014 The impact of E-cadherin expression on the prognosis of esophageal cancer: a meta-analysis. CI, HR
363  2014 The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer. IHC, MLNs
364  2014 The potential for targeting HER2 therapeutically in esophageal cancer - a grasp at straws? HER2
365  2014 The role of glycogen synthase kinase 3-beta in immunity and cell cycle: implications in esophageal cancer. GSK-3
366  2014 Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer. GC, GIT, TMs
367  2014 Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies. CIs, ORs, XPD
368  2014 XPD Asp312Asn polymorphism and esophageal cancer risk: an update meta-analysis based on 3928 cases and 6012 controls. CI, ORs, XPD
369  2014 [Application of cervical triangulating stapled anastomosis in minimally invasive esophagectomy]. EGA, MIE, TSA
370  2014 [Diagnostic values of salivary versus and plasma microRNA-21 for early esophageal cancer]. ---
371  2014 [Expressions and clinical significances of iASPP and caspase-9 in esophageal cancer]. RT-PCR, SP
372  2015 A Genetic Variant in miRNA-219-1 Is Associated with Risk of Esophageal Squamous Cell Carcinoma in Chinese Kazakhs. ESCC, LD, MALDI-TOF MS, qRT-PCR, SNPs
373  2015 A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer. CSS, ESCC, RDW
374  2015 A nomogram to predict prognostic values of various inflammatory biomarkers in patients with esophageal squamous cell carcinoma. CSS, ESCC, GPS, LMR, NLR, PLR
375  2015 A Phase 1/2 Study of Definitive Chemoradiation Therapy Using Docetaxel, Nedaplatin, and 5-Fluorouracil (DNF-R) for Esophageal Cancer. CRT, DNF-R, RD
376  2015 ABT-263 induces apoptosis and synergizes with chemotherapy by targeting stemness pathways in esophageal cancer. ---
377  2015 Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma. ESCC, miRNA, RT-PCR
378  2015 Angiopoietin-Like Protein 2 Acts as a Novel Biomarker for Diagnosis and Prognosis in Patients with Esophageal Cancer. ANGPTL2
379  2015 Anti-Tumor Effects of Peptide Therapeutic and Peptide Vaccine Antibody Co-targeting HER-1 and HER-2 in Esophageal Cancer (EC) and HER-1 and IGF-1R in Triple-Negative Breast Cancer (TNBC). TNBC
380  2015 Association between Cytotoxic T-lymphocyte antigen 4 (CTLA-4) +49 G>A (rs231775) polymorphism and esophageal cancer: from a case-control study to a meta-analysis. CTLA-4, PCR-LDR
381  2015 Association between glutathione S-transferases P1 Ile105Val polymorphism and susceptibility to esophageal cancer: evidence from 20 case-control studies. GSTP1, ORs
382  2015 Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population. CBM, CNKI
383  2015 Association of miR-21 with esophageal cancer prognosis: a meta-analysis. CI, HRs
384  2015 Association of the p53 Arg72Pro polymorphism with esophageal cancer in Chinese populations: a meta-analysis. CI, OR
385  2015 Atlas of the thoracic lymph nodal delineation and recommendations for lymph nodal CTV of esophageal squamous cell cancer in radiation therapy from China. CTVn, ENI, ESCC, JES
386  2015 CD44, SHH and SOX2 as novel biomarkers in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. CSS, DFS, IHC, nCR, nCRT
387  2015 Chemokines and their receptors in esophageal cancer--the systematic review and future perspectives. SDF-1
388  2015 Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer. CTCs
389  2015 Clinical significance of ALDH2 rs671 polymorphism in esophageal cancer: evidence from 31 case-control studies. ALDH2, CI, OR
390  2015 Clinicopathological characteristics of esophageal squamous cell carcinoma in patients younger than 50 years. ---
391  2015 Clinicopathological significance of matrix metalloproteinase-7 protein expression in esophageal cancer: a meta-analysis. CI, LN, ORs, PRC
392  2015 Comparing treatment plan in all locations of esophageal cancer: volumetric modulated arc therapy versus intensity-modulated radiotherapy. IMRT, PTVs, VMAT
393  2015 Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5-FU) and cisplatin for locally advanced resectable esophageal cancer. 5-FU, AJCC, CCRT, pCR
394  2015 Consumption of hot beverages and foods and the risk of esophageal cancer: a meta-analysis of observational studies. CI, OR
395  2015 Correlation of CYP1A1 and GSTM1 gene polymorphisms and environmental factors to familial aggregation of esophageal cancer among the Kazakh ethnic group in Xinjiang. ---
396  2015 Current advances in esophageal cancer proteomics. ---
397  2015 Discrimination of normal and esophageal cancer plasma proteomes by MALDI-TOF mass spectrometry. ---
398  2015 Early esophageal cancer screening in China. ---
399  2015 Endoscopic palliation of advanced esophageal cancer. ---
400  2015 Evaluating the Association of Eight Polymorphisms with Cancer Susceptibility in a Han Chinese Population. FDR, GC, GWASs, LC, NSCLC, SNPs
401  2015 Evaluation of the germline single nucleotide polymorphism rs583522 in the TNFAIP3 gene as a prognostic marker in esophageal cancer. SNP
402  2015 Five miRNAs Considered as Molecular Targets for Predicting Esophageal Cancer. DEMs, PCA
403  2015 Galectin-3 knockdown increases gefitinib sensitivity to the inhibition of EGFR endocytosis in gefitinib-insensitive esophageal squamous cancer cells. EGFR, ESCC
404  2015 Gastric and esophageal cancers incidence mapping in golestan province, iran: using bayesian-gibbs sampling. GC, RR
405  2015 Gene-environment interactions in esophageal cancer. EHs, GSTs, NATs, SULTs, UGTs
406  2015 Genetic variants at 6p21, 10q23, 16q21 and 22q12 are associated with esophageal cancer risk in a Chinese Han population. CI, CIs, GWAS, HWE, OR
407  2015 Heterozygote of TAP1 Codon637 decreases susceptibility to HPV infection but increases susceptibility to esophageal cancer among the Kazakh populations. HPV, PCR-RFLP, TAP
408  2015 High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes? JGA, NTT
409  2015 HPV-16 E6 promotes cell growth of esophageal cancer via downregulation of miR-125b and activation of Wnt/beta-catenin signaling pathway. HPV
410  2015 Impact of ABO blood group on the prognosis of patients undergoing surgery for esophageal cancer. DFS, OS
411  2015 Impact of neoadjuvant chemoradiation on lymph node status in esophageal cancer: post hoc analysis of a randomized controlled trial. CI, HR, LNs, nCRT, NLNi
412  2015 Implication of lncRNAs in pathogenesis of esophageal cancer. lncRNAs
413  2015 Increased risk of death due to heart disease after radiotherapy for esophageal cancer. HDRD, HDSS, HR, RT, SEER
414  2015 Intratumoral polymorphonuclear granulocyte is associated with poor prognosis in squamous esophageal cancer by promoting epithelial-mesenchymal transition. PMN
415  2015 Involved field irradiation for the treatment of esophageal cancer: is it better than elective nodal irradiation? ENI, IFI
416  2015 Joint Disease Mapping of Two Digestive Cancers in Golestan Province, Iran Using a Shared Component Model. GC
417  2015 Lack of association between EPHX1 polymorphism and esophageal cancer risk: evidence from meta-analysis. EPHX1, ORs
418  2015 Laparoscopic Gastric Mobilization Reduces Postoperative Mortality After Esophageal Cancer Surgery: A French Nationwide Study. LGM, POM
419  2015 Low Expression of miR-491 Promotes Esophageal Cancer Cell Invasion by Targeting TPX2. miRNAs
420  2015 Management of esophageal stenting-associated esophagotracheal fistula, tracheal stenosis and tracheal rupture: a case report and review of the literature. SES
421  2015 Metformin enhances radiation response of ECa109 cells through activation of ATM and AMPK. IR
422  2015 miR-204 inhibits invasion and epithelial-mesenchymal transition by targeting FOXM1 in esophageal cancer. EMT, FOXM1, miR-204, miRNAs
423  2015 MiR-499 Enhances the Cisplatin Sensitivity of Esophageal Carcinoma Cell Lines by Targeting DNA Polymerase beta. BER
424  2015 miRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy. miRNA
425  2015 Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus. MAGE, mRNA
426  2015 Palliative Endoscopic Therapy of Esophageal Cancer. ---
427  2015 Patterns of Esophageal Cancer in the National Cancer Institute at the University of Gezira, in Gezira State, Sudan, in 1999-2012. ADC, NCI-UG, SCC
428  2015 Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer. CRP, NeoTr, PBPC, PFR
429  2015 Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study. CI, CRT, HR, OR, pCR
430  2015 Problems and needs in patients with incurable esophageal and pancreaticobiliary cancer: a descriptive study. EORTC, LOA, PBC, PNPC
431  2015 Prognostic markers in esophageal cancer: from basic research to clinical use. ---
432  2015 Prognostic role of serum C-reactive protein in esophageal cancer: a systematic review and meta-analysis. CI, CRP, HR, OS
433  2015 Prognostic significance of neutrophil-to- lymphocyte ratio in esophageal cancer: a meta-analysis. CI, DFS, HR, NLR, OS
434  2015 Prognostic Value of the Circumferential Resection Margin in Esophageal Cancer Patients After Neoadjuvant Chemoradiotherapy. CAP, CRM, DFS, LRFS, nCRT, RCP
435  2015 Prolonged postoperative length of stay is associated with poor overall survival after an esophagectomy for esophageal cancer. 3FLND, LOS, OS
436  2015 Regulation of beta-catenin-mediated esophageal cancer growth and invasion by miR-214. miRNAs
437  2015 Self-expanding covered metallic stent as a bridge to surgery in esophageal cancer: impact on oncologic outcomes. SEMSs
438  2015 Sociodemographic Parameters of Esophageal Cancer in Northwest India: A Regional Cancer Center Experience of 10 Years. ---
439  2015 STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells. miRNAs, STAT3
440  2015 Survivin over-expression is correlated with a poor prognosis in esophageal cancer patients. HR
441  2015 Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy. BMDCs
442  2015 The application of linear endoscopic ultrasound in the patients with esophageal anastomotic strictures. EUS
443  2015 The combination of preoperative serum C-reactive protein and carcinoembryonic antigen is a useful prognostic factor in patients with esophageal squamous cell carcinoma: a combined ROC analysis. AUC, CEA, CRP, CSS, ESCC
444  2015 The correlation between high body mass index and survival in patients with esophageal cancer after curative esophagectomy: evidence from retrospective studies. BMI, CI, DFS, EAC, ESCC, H-BMI, HR, OS
445  2015 The prognostic value of irradiated lung volumes on the prediction of intra-/ post-operative mortality in patients after neoadjuvant radiochemotherapy for esophageal cancer. A retrospective multicenter study. 5-FU, DVH, nRCT
446  2015 Tumor recurrence and in-field control after multimodality treatment of locally advanced esophageal cancer. RTV
447  2015 Upregulated KLK10 inhibits esophageal cancer proliferation and enhances cisplatin sensitivity invitro. KLK10
448  2015 Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. lncRNAs
449  2015 Using aptamers to elucidate esophageal cancer clinical samples. EACA, EpCAM, ESCC, UEC
450  2015 Viruses, Other Pathogenic Microorganisms and Esophageal Cancer. EAC, EBV, ESCC, HPV
451  2015 Volumetric modulated arc therapy vs. c-IMRT for the treatment of upper thoracic esophageal cancer. c-IMRT, CI, MUs, OARs, TT, VMAT
452  2015 XPD Lys751Gln polymorphisms and the risk of esophageal cancer: an updated meta-analysis. CIs, ORs
453  2016 A germline predictive signature of response to platinum chemotherapy in esophageal cancer. AUC, DMET, SNPs
454  2016 Advances in Radiotherapy Management of Esophageal Cancer. RT
455  2016 alpha-Solanine Modulates the Radiosensitivity of Esophageal Cancer Cells by Inducing MicroRNA 138 Expression. CCK-8, FCM
456  2016 Association Studies of CYP1A1 Exon7 Polymorphism and -GSTM1 Interaction with Esophageal Cancer Risk: a Meta-Analysis in the Chinese Population. CIs, ORs
457  2016 Bayesian regression analyses of radiation modality effects on pericardial and pleural effusion and survival in esophageal cancer. CRT, pbe, PCE, PE, SCR
458  2016 Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer. EGC, FP
459  2016 Clinical and epidemiologic variations of esophageal cancer in Tanzania. ORCI
460  2016 Common Polymorphisms in IL-27 Genes May Contribute to Risk of Various Human Diseases in Asian Populations: A Meta-Analysis. COPD, ITP, OC, ORs, SLE, TB, UC
461  2016 Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3Dconformal radiotherapy or VMAT. 3DCRT, CRT, OAR, PTV, VMAT
462  2016 Comparison of postoperative immune function in patients with thoracic esophageal cancer after video-assisted thoracoscopic surgery or conventional open esophagectomy. NK, POD, PrD, VATS
463  2016 Convergent evidence from systematic analysis of GWAS revealed genetic basis of esophageal cancer. eQTL, GWAS, SNPs
464  2016 Correlations of Promoter Methylation in WIF-1, RASSF1A, and CDH13 Genes with the Risk and Prognosis of Esophageal Cancer. CDH13, RASSF1A, RT-PCR, WIF-1
465  2016 Current status of proteomics of esophageal carcinoma. ---
466  2016 Determining the optimal number of lymph nodes harvested during esophagectomy. DFS, LNs, OS
467  2016 Dietary Flavonols Intake and Risk of Esophageal and Gastric Cancer: A Meta-Analysis of Epidemiological Studies. GC, ORs
468  2016 Dietary Patterns and Risk of Esophageal Cancer Mortality: The Japan Collaborative Cohort Study. CIs, HRs
469  2016 Differences in esophageal cancer characteristics and survival between Chinese and Caucasian patients in the SEER database. EACs, ESCCs, OS, SEER
470  2016 Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. BE, EAC, miRNAs
471  2016 Distribution of FDG-avid nodes in esophageal cancer: implications for radiotherapy target delineation. CTV, LNM, RT
472  2016 Drinking water: a risk factor for high incidence of esophageal cancer in Anyang, China. ---
473  2016 Effect and mechanism of PAR-2 on the proliferation of esophageal cancer cells. PAR-2
474  2016 Effect of SNX-2112 on proliferation of esophageal cancer cells via regulation of excision repair cross-complementing 1, epidermal growth factor receptor, and p53 expression. EGFR, ERCC1
475  2016 Effect of YAP1 silencing on esophageal cancer. ---
476  2016 Effects of Minimally Invasive Esophagectomy and Open Esophagectomy on Circulating Tumor Cell Level in Elderly Patients with Esophageal Cancer. CTC, DAS-ELISA, MIE, OE
477  2016 Esophagus cancer and occupational exposure to asbestos: results from a meta-analysis of epidemiology studies. CIs, SMRs
478  2016 Etiology and Prevention of Esophageal Cancer. EAC, ESCC, GCA
479  2016 Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer. ---
480  2016 Factors Associated with Upper Gastrointestinal Cancer Occurrence After Endoscopy that Did Not Diagnose Cancer. EGD, GC, PEUGIC, UGIC
481  2016 G648C variant of DNA polymerase beta sensitizes esophageal cancer to chemotherapy. G648C
482  2016 Gastrointestinal cancers in India: Treatment perspective. CRC, GC, HCC, PC
483  2016 Gene silencing of galectin-3 changes the biological behavior of Eca109 human esophageal cancer cells. si
484  2016 Glutathione S-transferase M1 polymorphism and esophageal cancer risk: An updated meta-analysis based on 37 studies. CIs, GSTM1, ORs
485  2016 Hormonal and reproductive factors and risk of esophageal cancer in women: a meta-analysis. RRs
486  2016 Identification of a lncRNA involved functional module for esophageal cancer subtypes. BE, DE, DE-PCGs, EAC, ESCC
487  2016 Impact of the number of resected lymph nodes on survival after preoperative radiotherapy for esophageal cancer. CI, CSS, HR, OS, RLNs, SEER
488  2016 Implantation of esophageal cancer onto post-dissection ulcer after gastric endoscopic submucosal dissection. EGD, ESD, GC, SCC
489  2016 Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients. MALAT1, qRT-PCR
490  2016 Increased Prevalence of Esophageal Cancer in Areas with High Levels of Nickel in Farm Soils. OC
491  2016 Inhibition of miR-196a affects esophageal cancer cell growth in vitro. ---
492  2016 Interventional Therapy of Esophageal Cancer. ---
493  2016 Involvement of F-box proteins in esophageal cancer (Review). FBPs
494  2016 lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer. ceRNA, lncRNAs, UCA1
495  2016 Longitudinal, observational study on associations between postoperative nutritional vitamin D supplementation and clinical outcomes in esophageal cancer patients undergoing esophagectomy. DFS, GEEs, OS, QOL
496  2016 Mapping patterns of nodal metastases in esophageal carcinoma: rethinking the clinical target volume for supraclavicular nodal irradiation. CTV, ENI, ESCC, LN, SCV
497  2016 MDM2 gene amplification in esophageal carcinoma. EAC, FISH, MDM2, qPCR, SCC
498  2016 miR-1 suppresses the growth of esophageal squamous cell carcinoma invivo and invitro through the downregulation of MET, cyclin D1 and CDK4 expression. CDK4, ESCC, HGF
499  2016 miR-221 Mediates Chemoresistance of Esophageal Adenocarcinoma by Direct Targeting of DKK2 Expression. 5-FU, EAC, miRNAs
500  2016 MiR-328 suppresses the survival of esophageal cancer cells by targeting PLCE1. miRNAs, PLCE1
501  2016 Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell. BRCA2, GST, LIMD1, shRNAs
502  2016 Overexpression of A613T and G462T variants of DNA polymerase beta weakens chemotherapy sensitivity in esophageal cancer cell lines. G462T
503  2016 Overexpression of VEGF-C correlates with a poor prognosis in esophageal cancer patients. RT-PCR, VEGF-C
504  2016 Plasma Phosphatidylcholines Fatty Acids in Men with Squamous Cell Esophageal Cancer: Chemoradiotherapy Improves Abnormal Profile. CRT, FA, PC, PUFA, SCD1
505  2016 Positive esophageal proximal resection margin: an important prognostic factor for esophageal cancer that warrants adjuvant therapy. OS
506  2016 Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus. CT, DFS, PET
507  2016 Poultry and fish intake and risk of esophageal cancer: A meta-analysis of observational studies. CIs, ESCC, SRRs
508  2016 Predictive role of host constitutive variants in neoadjuvant therapy of esophageal cancer. ---
509  2016 Prognostic factors in patients after definitive chemoradiation using involved-field radiotherapy for esophageal cancer in a phase II study. CRT, GTV, IFRT, OS, RDI
510  2016 Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancer. AC, AC, HR, MTV, OS, TL, TLG
511  2016 Proton beam therapy for the treatment of esophageal cancer. IMRT, PBT, RT
512  2016 Quality-of-life measures as predictors of post-esophagectomy survival of patients with esophageal cancer. QOL
513  2016 Racial disparities in esophageal cancer survival after surgery. ---
514  2016 RAD51 regulates CHK1 stability via autophagy to promote cell growth in esophageal squamous carcinoma cells. 3-MA, HCQ
515  2016 Radiation dose escalation by simultaneous modulated accelerated radiotherapy combined with chemotherapy for esophageal cancer: a phase II study. SMART
516  2016 Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer. HR, IMRT, SEER
517  2016 Radiofrequency hyperthermia-enhanced herpes simplex virus-thymidine kinase/ganciclovir direct intratumoral gene therapy of esophageal squamous cancers. ESCa, PBS
518  2016 Rates and predictors of progression to esophageal carcinoma in a large population-based Barrett's esophagus cohort. BE, PPI
519  2016 Self-Expandable Metal Stents in Esophageal Cancer in a High HIV Prevalence Area: A Survival Analysis and Evaluation of Prediction Scores. HIV, SEMS
520  2016 SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016). ---
521  2016 Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer. CEA, CRP
522  2016 Silencing of CXCR2 and CXCR7 protects against esophageal cancer. ESCC, IHC, siRNA
523  2016 Specific cellular accumulation of photofrin-II in EC cells promotes photodynamic treatment efficacy in esophageal cancer. HPLC, PDT
524  2016 Surgery Combined with Radiotherapy Improved Survival in Metastatic Esophageal Cancer in a Surveillance Epidemiology and End Results Population-based Study. OS, RT, SEER
525  2016 Survival after neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: A meta-analysis. CRT, CT, HR
526  2016 Synchronous second primary cancers in patients with squamous esophageal cancer: clinical features and survival outcome. PET-CT, SPC
527  2016 Temporal trends of esophageal disorders by age in the Cerner Health Facts database. BE, GERD
528  2016 The Antiproliferative Effect of Moringa oleifera Crude Aqueous Leaf Extract on Human Esophageal Cancer Cells. ATP, MO, MOE, PS, SA
529  2016 The management of patients with esophageal cancer and coronary artery stenosis undergoing radiotherapy or concurrent chemoradiotherapy: a single-center experience. CCRT, CR, ORR, OS, PFS, RT
530  2016 The PER (Preoperative Esophagectomy Risk) Score: A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Patients with Surgically Treated Esophageal Cancer. DFS, HR, OS, PER
531  2016 The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer. CEA, CRP, SCC-Ag
532  2016 Tooth loss is associated with increased risk of esophageal cancer: evidence from a meta-analysis with dose-response analysis. ---
533  2016 TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing. ---
534  2016 Transglutaminase 3 protein modulates human esophageal cancer cell growth by targeting the NF-kappaB signaling pathway. TGM3
535  2016 Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis. EAC, SCC
536  2016 Tumor profiling of co-regulated receptor tyrosine kinase and chemoresistant genes reveal different targeting options for lung and gastroesophageal cancers. GC, NSCLC, RTKs
537  2016 [Current status and future prospect of internal medicine treatment for advanced esophageal cancer]. ---
538  2016 [Current status and prospect of treatment for esophageal cancer in the era of precision medicine]. ---
539  2016 [Prognostic value of circulating tumor cells and disseminated tumor cells in patients with esophageal cancer: a meta-analysis]. CTCs, DFS/PFS, DTCs, HR, OR, OS, RR
540  2016 [Relationship between metastatic lymph node and prognosis of esophageal cancer patients treated with following radical esophagectomy]. AUC, LNR
541  2017 A comparative study of target volumes based on 18F-FDG PET-CT and ten phases of 4DCT for primary thoracic squamous esophageal cancer. CI, DI, GTV, IGTV, SUV
542  2017 Analysis of salivary microRNA expression profiles and identification of novel biomarkers in esophageal cancer. E2F, MMP, MYC
543  2017 Analysis of the causes of failure after radical surgery in patients with PT3N0M0 thoracic esophageal squamous cell carcinoma and consideration of postoperative radiotherapy. LRR
544  2017 Anti-tumor efficacy of theliatinib in esophageal cancer patient-derived xenografts models with epidermal growth factor receptor (EGFR) overexpression and gene amplification. EGFR, FISH, PDECX
545  2017 APIO-EE-9 is a novel Aurora A and B antagonist that suppresses esophageal cancer growth in a PDX mouse model. PDX
546  2017 Association of ALDH3B2 gene polymorphism and risk factors with susceptibility of esophageal squamous cell carcinoma in a Chinese population: a case-control study involving 2,358 subjects. ESCC, SNPs
547  2017 Basis for molecular diagnostics and immunotherapy for esophageal cancer. ---
548  2017 Berberine displays antitumor activity in esophageal cancer cells in vitro. PI
549  2017 C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis. CBM, CIs, CNKI, DFS, DSS, EAC, ESCC, HRs, OS
550  2017 Cancer stem cells with increased metastatic potential as a therapeutic target for esophageal cancer. CSCs, EMT, nCRT
551  2017 CDKN2A methylation in esophageal cancer: a meta-analysis. AUC, OR
552  2017 Circulating Tumor Cells in Esophageal Cancer. CTC
553  2017 Clinical burden of preoperative albumin-globulin ratio in esophageal cancer patients. AGR, CEA, DFS, OS
554  2017 Clinical implications of endoscopic ultrasonography non-traversability in patients with locoregional esophageal cancer receiving multimodality therapy. CRT, EUS
555  2017 Clinical Outcomes of Resectable Esophageal Cancer with Supraclavicular Lymph Node Metastases Treated with Curative Intent. dCRT, SCLN, UICC
556  2017 Comparative evaluation of target volumes defined by deformable and rigid registration of diagnostic PET/CT to planning CT in primary esophageal cancer. COM, DIR, DSC, F-FDG, GTVs, PET/CT, RIR
557  2017 Comparative Outcomes After Definitive Chemoradiotherapy Using Proton Beam Therapy Versus Intensity Modulated Radiation Therapy for Esophageal Cancer: A Retrospective, Single-Institutional Analysis. CRT, DMFS, HR, IMRT, LRFFS, OS, PBT, PFS
558  2017 Comparison of IMRT versus 3D-CRT in the treatment of esophagus cancer: A systematic review and meta-analysis. IMRT, OS
559  2017 Correlation between NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and increased risk of esophageal cancer: evidence from a meta-analysis. CI, NQO1, OR, POR
560  2017 Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis. CD, DCR, ORR, OS, QOL
561  2017 Diabetes mellitus carries a risk of esophageal cancer: A meta-analysis. CIs, DM, EAC, RRs, T2DM
562  2017 Different definitions of esophagus influence esophageal toxicity prediction for esophageal cancer patients administered simultaneous integrated boost versus standard-dose radiation therapy. AET, DEs, ESOinfield, ESOinfield-tumor, ESOwhole-tumor, LET, SD-IMRT, SIB-IMRT
563  2017 Differential expression of Kindlin-1 and Kindlin-2 correlates with esophageal cancer progression and epidemiology. IHC
564  2017 Dosimetric benefits of automation in the treatment of lower thoracic esophageal cancer: Is manual planning still an alternative option? CI, Dmax, DVH, HI, OARs, PTV, TPS, VMAT
565  2017 Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells in vivo and in vitro. NC, RT-qPCR, XIAP
566  2017 Effect of Extending the Original Eligibility Criteria for the CROSS Neoadjuvant Chemoradiotherapy on Toxicity and Survival in Esophageal Cancer. CI, CROSS, CTCAE, nCRT, OS
567  2017 Effect of Food Additive Citric Acid on The Growth of Human Esophageal Carcinoma Cell Line EC109. LDH, MMP
568  2017 Efficacy of Additional Surgical Resection After Endoscopic Submucosal Dissection for Superficial Esophageal Cancer. ASR, AT, ESD, PSR, SEC
569  2017 Endoscopic ultrasound staging for early esophageal cancer: Are we denying patients neoadjuvant chemo-radiation? EUS, PET
570  2017 Esophageal Cancer in Israel has Unique Clinico-Pathological Features: A Retrospective Study. ADC, SCC
571  2017 Esophageal cancer in Kenya. ---
572  2017 Esophageal cancer's 100 most influential manuscripts: a bibliometric analysis. ---
573  2017 Esophageal Cancer: Genomic and Molecular Characterization, Stem Cell Compartment and Clonal Evolution. BE, CSCs, EAC, ESCC
574  2017 Expression and significance of GRHL2 in esophageal cancer. GRHL2, HIF-1alpha, VEGF
575  2017 FoxC1 promotes epithelial-mesenchymal transition through PBX1 dependent transactivation of ZEB2 in esophageal cancer. EMT, FoxC1, PBX1
576  2017 FOXK1 plays an oncogenic role in the development of esophageal cancer. FOXK1
577  2017 Functional evidence that the self-renewal gene NANOG regulates esophageal squamous cancer development. CCND1, SC
578  2017 Gene function analysis and underlying mechanism of esophagus cancer based on microarray gene expression profiling. CXCR-7, DEGs, GEO, IL-8, Pathway-net, signal-net
579  2017 Global trends in esophageal cancer. AC, SCC
580  2017 Glucose Oncometabolism of Esophageal Cancer. ---
581  2017 Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling. ---
582  2017 HPV infection and p53 and p16 expression in esophageal cancer: are they prognostic factors? ESCC, HPV
583  2017 Hypoxia and hypoxia response-associated molecular markers in esophageal cancer: A systematic review. 18F-FETNIM
584  2017 Identification of Herb Pairs in Esophageal Cancer. CHM, OS
585  2017 Identification of risk factors and the pattern of lower cervical lymph node metastasis in esophageal cancer: implications for radiotherapy target delineation. LNM
586  2017 Impact of Endoscopic Ultrasonography on 18F-FDG-PET/CT Upfront Towards Patient Specific Esophageal Cancer Treatment. EUS, FNA
587  2017 In Vitro and In Vivo Assessment of Docetaxel Formulation Developed for Esophageal Stents. DTX, SEMS
588  2017 Influence of tumor response and treatment schedule on the distribution of tumor recurrence in esophageal cancer patients treated with neoadjuvant chemoradiotherapy. nCRT, pCR
589  2017 Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity. CI, dCRT, HR, IMRT, LR, OS, PFS
590  2017 Is endoscopic ultrasound examination necessary in the management of esophageal cancer? ER, EUS, PET
591  2017 Joint Effects of Low Body Mass Index and Alcohol Consumption on Developing Esophageal Squamous Cell Cancer: a Korean Nationwide Population-Based Cohort Study ESCC
592  2017 Knockdown of DDX5 Inhibits the Proliferation and Tumorigenesis in Esophageal Cancer. EMT
593  2017 Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer. lncRNA-HOTAIR, qRT-PCR
594  2017 Long noncoding RNA MALAT1 affects the efficacy of radiotherapy for esophageal squamous cell carcinoma by regulating Cks1 expression. ESCC, MALAT1, siRNAs
595  2017 Long-term survival and toxicity outcomes of intensity modulated radiation therapy for the treatment of esophageal cancer: A large single-institutional cohort study. IMRT, OS
596  2017 Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy. ALC, CRT, G4 nadir, MVA
597  2017 Metabolic Perturbation and Potential Markers in Patients with Esophageal Cancer. ROC, TCA
598  2017 Metabolomic profiling reveals potential biomarkers in esophageal cancer progression using liquid chromatography-mass spectrometry platform. ESCC, LC-MS
599  2017 miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42. ESCC, NC
600  2017 MiR-148a modulates HLA-G expression and influences tumor apoptosis in esophageal squamous cell carcinoma. ESCC, HLA-G, miR
601  2017 miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer. CRI
602  2017 miR-30b inhibits cancer cell growth, migration, and invasion by targeting homeobox A1 in esophageal cancer. HOXA1, miRNAs
603  2017 Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer. IMRT, IPW, LOS, nCRT, PBT, RT
604  2017 Neoadjuvant Therapy for Esophageal Adenocarcinoma in the Community Setting-Practice and Outcomes. ---
605  2017 Non responders to neoadjuvant chemoradiation for esophageal cancer: why better prediction is necessary. nCRT, OS, pCR, pNR, SCC
606  2017 Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer. EMT, GM-CSF
607  2017 Outcomes of aggressive treatment in esophageal cancer patients with synchronous solitary brain metastasis. CRT, RT, WBRT
608  2017 Outcomes of nutritional interventions to treat dysphagia in esophageal cancer: a population-based study. FT, LOS, PN
609  2017 Overexpression of SKP2 Inhibits the Radiation-Induced Bystander Effects of Esophageal Carcinoma. MN, RIBE, Skp2
610  2017 PADI4 rs2240337 G>A polymorphism is associated with susceptibility of esophageal squamous cell carcinoma in a Chinese population. ESCC, SNPs
611  2017 Pathological complete response in patients with esophageal cancer after the trimodality approach: The association with baseline variables and survival-The University of Texas MD Anderson Cancer Center experience. OS, pathCR, RFS, SRCs
612  2017 Patterns of Care and Treatment Outcomes of ElderlyPatients with Stage I Esophageal Cancer: Analysis of the National Cancer Data Base. CI, CRT, ESO, HR, LE, OBS, OS
613  2017 Performance of 18-fluoro-2-deoxyglucose positron emission tomography for esophageal cancer screening. EGD, FDG-PET
614  2017 Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment 18F-FDG PET/CT Imaging. AUCs, nCRT
615  2017 Prevalence of anastomotic leak and the impact of indocyanine green fluorescein imaging for evaluating blood flow in the gastric conduit following esophageal cancer surgery. AL, ICG
616  2017 Primary radio(chemo)therapy for esophageal cancer in elderly patients: are efficiency and toxicity comparable with younger patients? ACCI
617  2017 Pro-Apoptotic Effects of JDA-202, a Novel Natural Diterpenoid, on Esophageal Cancer Through Targeting Peroxiredoxin I. ERK, MAPK, NAC, Prx I, ROS, siRNA
618  2017 Prognostic significance and role in TNM stage of tumor deposits in esophageal cancer. TDN, TDP, TDs
619  2017 Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. NAC, OS, PNI, RFS
620  2017 Promising immunotherapies for esophageal cancer. ---
621  2017 Qat use and esophageal cancer in Ethiopia: A pilot case-control study. ---
622  2017 Recursive Partitioning Analysis Identifies Pretreatment Risk Groups for the Utility of Induction Chemotherapy Before Definitive Chemoradiation Therapy in Esophageal Cancer. dCRT, IC, PET, PFS, RPA
623  2017 Research progress on the relationship between zinc deficiency, related microRNAs, and esophageal carcinoma. Zn
624  2017 RNA-Seq analysis of human cell lines established from normal and neoplastic esophageal squamous epithelium. DDBJ, ESCC
625  2017 RNAi-mediated TCF-3 gene silencing inhibits proliferation of Eca-109 esophageal cancer cells by inducing apoptosis. FCM, NC, RT-qPCR, siTCF-3, TCF3
626  2017 S-1 versus S-1 plus cisplatin concurrent intensity modulated radiation therapy in the treatment of esophageal squamous cell carcinoma: Study protocol for a randomized controlled phase II trial. ---
627  2017 Safety and feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy for esophageal cancer. NAC
628  2017 Sites of metastasis and overall survival in esophageal cancer: a population-based study. DM, OS
629  2017 Stem cell factor in the serum of patients with esophageal cancer in relation to its histological types. AC, CEA, ESCC, HGFs, SCF
630  2017 Stereotactic radiotherapy in the treatment of local recurrences of esophageal cancer. SBRT
631  2017 Surgical management of esophageal cancer. ---
632  2017 Survival benefit evaluation of radiotherapy in esophageal cancer patients aged 80 and older. CSS, HR, OS, RT
633  2017 Survival benefit of neoadjuvant versus adjuvant radiotherapy in lymph node positive esophageal cancer: a population based analysis. LN, RT, SCC, SEER
634  2017 The adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives. AP
635  2017 The association of plasma fibrinogen with clinicopathological features and prognosis in esophageal cancer patients. CNKI, DFS, HR, LNM, OS, RFS
636  2017 The impact of gender, race, socioeconomic status, and treatment on outcomes in esophageal cancer: A population-based analysis. CI, HR, OS, SES
637  2017 The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy. CRT, SCC
638  2017 The influence of marital status on the survival of patients with esophageal cancer: a population-based, propensity-matched study. CI, CSS, HR, HR, OS, SEER
639  2017 The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis. COX-2, HRs, OS
640  2017 The Relation of HPV Infection and Expression of p53 and p16 Proteins in Esophageal Squamous Cells Carcinoma. ESCC, HR-HPV, IHC
641  2017 The relationship between eosinophilic esophagitis and esophageal cancer. EoE
642  2017 The Relationship between Serum Selenium and Zinc with Gastroesophageal Cancers in the Southeast of Iran. GC, Se, Zn
643  2017 Total Oxidant/Antioxidant Status in Sera of Patients with Esophageal Cancer. OSI, TAS, TOS
644  2017 Trends in gastric and esophageal cancer incidence in northern Portugal (1994-2009) by subsite and histology, and predictions for 2015. APC, GC
645  2017 Up-Regulation of MicroRNA-133a Inhibits the MEK/ERK Signaling Pathway to Promote Cell Apoptosis and Enhance Radio-Sensitivity by Targeting EGFR in Esophageal Cancer In Vivo and In Vitro. miR-133a, NC
646  2017 Updated incidence rates and risk factors of esophageal cancer in Nan'ao Island, a coastal high-risk area in southern China. OR
647  2017 Vasculogenic mimicry is associated with increased tumor-infiltrating neutrophil and poor outcome in esophageal squamous cell carcinoma. ESCC, PAS, TIN, TNM, VM
648  2017 [A comparison between 3.0 T MRI and histopathology for preoperative T staging of potentially resectable esophageal cancer]. ---
649  2018 "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis." CRC, DT, GC
650  2018 A meta-analysis on salvage surgery as a potentially curative procedure in patients with isolated local recurrent or persistent esophageal cancer after chemoradiotherapy. CI, nCRT, OS
651  2018 A retrospective study of treatment for curative synchronous double primary cancers of the head and neck and the esophagus. CSC-HE, HNC
652  2018 ABC Transporters and Their Role in the Neoadjuvant Treatment of Esophageal Cancer. ---
653  2018 Absence of HER2 Expression of Circulating Tumor Cells in Patients with Non-Metastatic Esophageal Cancer. AC, CTC, SCC
654  2018 Aging-related prognosis analysis of definitive radiotherapy for very elderly esophageal cancer. AJCC, DMFS, IMRT, LRFFS, NLR, NRI, OS, pGTV, RT
655  2018 Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis. CCR, dCRT, DMFS, OS, PFS, SCLN
656  2018 Artesunate enhances radiosensitivity of esophageal cancer cells by inhibiting the repair of DNA damage. ART, IR
657  2018 Association of low-activity ALDH2 and alcohol consumption with risk of esophageal cancer in Chinese adults: A population-based cohort study. ---
658  2018 Baseline Metabolic Risk Score and Postsurgical Esophageal Cancer-Specific Mortality: The Fujian Prospective Investigation of Cancer (FIESTA) Study. CI, FIESTA, HR, MRS
659  2018 Casticin inhibits esophageal cancer cell proliferation and promotes apoptosis by regulating mitochondrial apoptotic and JNK signaling pathways. ---
660  2018 Characteristics of Esophageal Cancer Cases in Tanzania. ---
661  2018 Circulating plasma microRNAs in the detection of esophageal squamous cell carcinoma. AUCs, ESCC
662  2018 Clinical assessment of airway stent placement in patients with malignant airway lesions. CCI, KPS, LC
663  2018 Clinical fate of T0N1 esophageal cancer: results from the National Cancer Database. AC, nCR, pCR, pPR, SCC
664  2018 Clinical significance of SUVmax on preoperative 18F-fluorodeoxyglucose positron emission tomography in patients who underwent R0-esophagectomy for esophageal cancer. RFS, SUV, SUV
665  2018 Clinicopathological and prognostic significance of circulating tumor cells in patients with esophageal cancer: a meta-analysis. CTCs, OS, PFS, RR
666  2018 Clinicopathological Features and Increased Expression of Toll-Like Receptor 4 of Gastric Cardia Cancer in a High-Risk Chinese Population. GCC, NGCC, TLR4
667  2018 Concept of histone deacetylases in cancer: Reflections on esophageal carcinogenesis and treatment. HDACs
668  2018 Concurrent chemoradiation therapy tailored to the older adults with esophageal cancer: state of the art and the future. dCRT, GA
669  2018 Consumption of garlic and its interactions with tobacco smoking and alcohol drinking on esophageal cancer in a Chinese population. CI, OR, SB
670  2018 Consumption of processed and pickled food and esophageal cancer risk: A systematic review and meta-analysis. CI, OR, RR
671  2018 Decoding the LncRNA transcriptome of esophageal cancer: identification of clinically relevant LncRNAs. GSEA
672  2018 Diabetes mellitus and the risk of gastrointestinal cancer in women compared with men: a meta-analysis of cohort studies. CC, CRC, DM, GC, HCC, PC, RC, RRR
673  2018 Dietary vitamin B intake and the risk of esophageal cancer: a meta-analysis. ---
674  2018 DNA methylation enzyme inhibitor RG108 suppresses the radioresistance of esophageal cancer. IHC
675  2018 Does the Margin Matter in Esophageal Cancer. CAP, CRM, RCP
676  2018 Early diagnostic potential of APC hypermethylation in esophageal cancer. BE, OS, RFS
677  2018 Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial. IC, OS, pCR, PET, SUV
678  2018 Effect of galectin-3 on vasculogenic mimicry in esophageal cancer cells. EphA2, MMP-2, VM
679  2018 Effect of polyglycolic acid sheet plus esophageal stent placement in preventing esophageal stricture after endoscopic submucosal dissection in patients with early-stage esophageal cancer: A randomized, controlled trial. ESD, PGA
680  2018 Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells. miRNA- 210, MTT, PCR, qRT-PCR
681  2018 Efficacy comparison of transcervical video-assisted mediastinoscopic lymphadenectomy combined with left transthoracic esophagectomy versus right transthoracic esophagectomy for esophageal cancer treatment. VAMLA
682  2018 Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer. EHDRBT, OS
683  2018 Enteral nutrition in esophageal cancer patients treated with radiotherapy: a Chinese expert consensus 2018. EN
684  2018 ESCC ATLAS: A population wide compendium of biomarkers for Esophageal Squamous Cell Carcinoma. ---
685  2018 Esophageal Adenocarcinoma with Extensive Metastasis to Unexpected Sites: A Case Report. UM
686  2018 Esophageal Cancer Clinical Presentation: Trends in the Last 3 Decades in a Large Italian Series. APCs
687  2018 Esophageal cancer in elderly patients: a population-based study. HR, OS, PSA, SEER
688  2018 Esophageal cancer in patients under 50: a SEER analysis. ECSS, OS, SEER
689  2018 Esophageal cancer male to female incidence ratios in Africa: A systematic review and meta-analysis of geographic, time and age trends. ESCC
690  2018 Factors Affecting Long-Survival of Patients with Esophageal Cancer Using Non-Mixture Cure Fraction Model CI
691  2018 Folate intake, serum folate, and risk of esophageal cancer: a systematic review and dose-response meta-analysis. ---
692  2018 Gastric cancer may share genetic predisposition with esophageal squamous cell carcinoma in Chinese populations. CI, EAC, ESCC, GC, OR, WGS
693  2018 Gene expression profiling reveals the plausible mechanisms underlying the antitumor and antimetastasis effects of Andrographis paniculata in esophageal cancer. AP
694  2018 GSTM1 and GSTT1 Gene Polymorphisms, Gene-Gene Interaction, and Esophageal Carcinoma Risk: Evidence from an Updated Meta-Analysis. CNKI, ESCC, ORs
695  2018 High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. ALC, MBD, nCRT, pCR, pCR
696  2018 Hospital of Diagnosis Influences the Probability of Receiving Curative Treatment for Esophageal Cancer. ---
697  2018 Identification of the key transcription factors in esophageal squamous cell carcinoma. DEGs, ESCC, GEO, GO, KEGG, qRT-PCR, TFs
698  2018 Incidence of Esophageal Cancer in Iran, a Population-Based Study: 2001-2015. ASRs, CI
699  2018 Increased total iron and zinc intake and lower heme iron intake reduce the risk of esophageal cancer: A dose-response meta-analysis. OR
700  2018 Indoleamine 2,3-dioxygenase 1 and overall survival of patients diagnosed with esophageal cancer. AC, IDO1, IHC, OS, PD-L1, SCC
701  2018 Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay. LOS, NIS
702  2018 Intake of Dietary One-Carbon Metabolism-Related B Vitamins and the Risk of Esophageal Cancer: A Dose-Response Meta-Analysis. CI, OR
703  2018 Intakes of citrus fruit and risk of esophageal cancer: A meta-analysis. CI, EAC, ESCC, RR
704  2018 Investigation of Dietary Factors and Esophageal Cancer Knowledge: Comparison of Rural Residents in High- and Low-incidence Areas. ---
705  2018 Involving the microRNA Targetome in Esophageal-Cancer Development and Behavior. SNPs
706  2018 LincRNA-ROR promotes metastasis and invasion of esophageal squamous cell carcinoma by regulating miR-145/FSCN1. ceRNA, DLR, ESCC, lincRNA-ROR, miRNA, qRT-PCR, RIP
707  2018 LncRNA MALAT1 promotes epithelial-to-mesenchymal transition of esophageal cancer through Ezh2-Notch1 signaling pathway. EMT, EZH2, MALAT1
708  2018 Long non-coding RNA FAL1 regulated cell proliferation through Akt pathway via targeting PDK1 in esophageal cancer cells. ChIP, FAL1
709  2018 Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications. ---
710  2018 Long Noncoding RNA GAS5 Promotes Proliferation, Migration, and Invasion by Regulation of miR-301a in Esophageal Cancer. GAS5, lncRNA
711  2018 Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion. dCRT, iCRT-S, LN, TBI
712  2018 Long-term pharyngeal dysphagia after esophagectomy for esophageal cancer-an investigation using videofluoroscopic swallow studies. PAS, QOL, VDS
713  2018 Long-term survival after multimodality therapy including surgery for metastatic esophageal cancer. CT, LN
714  2018 Low skeletal muscle mass in stented esophageal cancer predicts poor survival: A retrospective observational study. ---
715  2018 Management of pathologic node-positive disease following initial surgery for clinical T1-2 N0 esophageal cancer: patterns of care and outcomes from the national cancer data base. NCDB, OS
716  2018 Management of Unresectable T4b Esophageal Cancer: Practice Patterns and Outcomes From the National Cancer Data Base. CRT, CT, OS, RT
717  2018 Metabolic Tumor Volume Change Predicts Long-term Survival and Histological Response to Preoperative Chemotherapy in Locally Advanced Esophageal Cancer. HR, MTV, PFS, SUV
718  2018 MicroRNA-155 inversely correlates with esophageal cancer progression through regulating tumor-associated macrophage FGF2 expression. Arg-1, CCK-8, FGF-2, HUVEC, IL, iNOS, miR, qRT-PCR, TAMs, TNF-alpha
719  2018 MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP. OS, qRT-PCR
720  2018 Minimal Residual Disease in Head and Neck Cancer and Esophageal Cancer. DTC, HNSCC, MRD
721  2018 miR-144 functions as an oncomiR in KYSE-410 human esophageal carcinoma cell line in vitro and targets PURA. NC
722  2018 Modifiable factors and esophageal cancer: a systematic review of published meta-analyses. ---
723  2018 Molecular Diagnostics in Esophageal and Gastric Neoplasms: 2018Update. GC, HER-2
724  2018 Molecular landscape of esophageal cancer: implications for early detection and personalized therapy. EAC, ESCC
725  2018 Multi-institutional Analysis of Recurrence and Survival After Neoadjuvant Chemoradiotherapy of Esophageal Cancer: Impact of Histology on Recurrence Patterns and Outcomes. CRT, pCR, SCC
726  2018 NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway. EMT, NDRG2, p-Akt, XIAP
727  2018 Near infrared fluorescent peptide nanoparticles for enhancing esophageal cancer therapeutic efficacy. EPI
728  2018 Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology. CSS, DFS, nCRT
729  2018 Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure. dCRT, LR, nCRT-S, OS, PFS
730  2018 Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancer. CR, CRT
731  2018 Nutrition therapy in esophageal cancer-Consensus statement of the Gastroenterological Society of Taiwan. SEMS
732  2018 Paraoxonase 3 is involved in the multi-drug resistance of esophageal cancer. ---
733  2018 Patterns of Care and Outcomes of Elderly Esophageal Cancer Patients Not Meeting Age-based Criteria of the CROSS Trial. dCRT, nCRT-S, OS
734  2018 Peanut consumption associated with a reduced risk of esophageal squamous cell carcinoma: A case-control study in a high-risk area in China. CI, ESCC, OR
735  2018 POH1 Knockdown Induces Cancer Cell Apoptosis via p53 and Bim. CRC, HCC, siRNA
736  2018 Prevalence and Prognostic Significance of Extramural Venous Invasion in Patients with Locally Advanced Esophageal Cancer. CI, EMVI, HR, nCRT
737  2018 Prevalence of the integration status for human papillomavirus 16 in esophageal carcinoma samples. HPV, PCR
738  2018 Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis. CI, CSS, DFS, HR, OS, RDW
739  2018 Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: A systematic review and meta-analysis. CI, CSS, DFS, HR, NLR, OS, PFS, RFS
740  2018 Prognostic Role of Tumor-Infiltrating Lymphocytes in Esophagus Cancer: a Meta-Analysis. CSS, DFS, HRs, OS, TILs
741  2018 Prognostic significance of programmed death ligand-1 immunohistochemical expression in esophageal cancer: A meta-analysis of the literature. CI, DFS, HR, IHC, OS, PD-L1
742  2018 Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers. PGRN
743  2018 Propensity score analysis of 18-FDG PET/CT-enhanced staging in patients undergoing surgery for esophageal cancer. OS
744  2018 Proposed revision of N categories to the 8th edition AJCC-TNM staging system for non-surgical esophageal squamous cell cancer. AJCC-TNM, ESCC, LNs
745  2018 Radiation dose in neoadjuvant chemoradiation therapy for esophageal cancer: patterns of care and outcomes from the National Cancer Data Base. CRT, HD, LD, NCDB, OS
746  2018 Radiotherapy for esophageal carcinoma: dose, response and survival. ---
747  2018 RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma. DDR, DUB, ESCC, Ub, UIMC1
748  2018 Recent advancements in esophageal cancer treatment in Japan. JCOG, SCC, UICC
749  2018 Recurrence and prognostic model for identifying patients at risk for esophageal cancer after surgery. DFS, OS, RV
750  2018 Reduced mean platelet volume is associated with poor prognosis in esophageal cancer. MPV
751  2018 Risk factors and measures of pulmonary complications after thoracoscopic esophagectomy for esophageal cancer. COPD, PCs
752  2018 Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance. MLH1, OR
753  2018 Salvage Surgery for Esophageal Cancer: How to Improve Outcomes? AL, dCRT, OS, SALV
754  2018 Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets. AUC, miRNAs, TCGA
755  2018 Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. IMRT, nCRT, PBT
756  2018 Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway. EMT
757  2018 Spatial Analysis of Esophageal Cancer Mortality in a High-risk Population in China: Consistent Clustering Pattern in 1970-74 and 2011-13 ASMRs
758  2018 Targeting Orai1-mediated store-operated calcium entry by RP4010 for anti-tumor activity in esophagus squamous cell carcinoma. NF-kappaB
759  2018 The miR-199a-3p regulates the radioresistance of esophageal cancer cells via targeting the AK4 gene. ---
760  2018 The MR radiomic signature can predict preoperative lymph node metastasis in patients with esophageal cancer. AUC, LN
761  2018 The potential of herb medicines in the treatment of esophageal cancer. TCM
762  2018 The prevalence of lymph node metastasis for pathological T1 esophageal cancer: a retrospective study of 143 cases. LNM, pT1
763  2018 The prognostic impact of tumor length in esophageal cancer: Protocol for a systematic review and meta-analysis. CIs
764  2018 Trimodality therapy for esophageal cancer at high volume facilities is associated with improved postoperative outcomes and overall survival. HVFs, LVFs, OS
765  2018 Utilization of neoadjuvant intensity-modulated radiation therapy and proton beam therapy for esophageal cancer in the United States. IMRT, NCDB, OS, PBT, RT
766  2018 Water Carcinogenicity and Prevalence of HPV Infection in Esophageal Cancer Patients in Huaihe River Basin, China. 3-MC, HPV, PCR
767  2018 ypT0N+: the unusual patient with pathological complete tumor response but with residual lymph node disease after neoadjuvant chemoradiation for esophageal cancer, what's up? ADC, nCRT, OS, SCC, ypT0N0
768  2018 [Effects of minimally invasive versus open esophagectomy on circulating tumor cells in patients with esophageal cancer]. CTCs, MIE, OE
769  2019 A Diagnostic Algorithm That Combines Quantitative 18F-FDG PET Parameters and Contrast-Enhanced CT Improves Posttherapeutic Locoregional Restaging and Prognostication of Survival in Patients With Esophageal Cancer. AUC, CECT, MTV
770  2019 Comparative Study of Predictive Mortality Scores in Esophagectomy with Three-Field Lymph Node Dissection in Patients with Esophageal Cancer. P-Possum
771  2019 Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer. DFS, EEC, NLR, OS, RDW
772  2019 Esophageal cancer lymph node metastasis-associated gene signature optimizes overall survival prediction of esophageal cancer. LNM, mRNA
773  2019 Increased miR-203-3p and reduced miR-21-5p synergistically inhibit proliferation, migration, and invasion in esophageal cancer cells. Ran
774  2019 Knockdown of USP28 enhances the radiosensitivity of esophageal cancer cells via the c-Myc/hypoxia-inducible factor-1 alpha pathway. HIF-1alpha, USP28
775  2019 MicroRNA‑301a targets WNT1 to suppress cell proliferation and migration and enhance radiosensitivity in esophageal cancer cells. EMT, ESCC, IR